Pendulum Therapeutics Stock

pendulum.coHealthcareFounded: 2012Funding to Date: $112.76MM

Pendulum is a biotechnology company committed to developing novel interventions that target the human microbiome to improve the lives of patients suffering from a variety of diseases.

Register for Details

For more details on financing and valuation for Pendulum Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Pendulum Therapeutics.

Register Today

Team

Management Team

Colleen Cutcliffe Ph.D
Chief Executive Officer, Board Member & Co-Founder
Matthew Murphy JD
General Counsel
James Bullard Ph.D
Co-Founder, Chief Technology Officer & Secretary
John Eid Ph.D
Chief Scientific Officer, Board Member & Co-Founder
Mohan Iyer
Chief Operating Officer
Orville Kolterman
Chief Medical Officer

Board Members

Adam D'Augelli
True Ventures
Peter Hutt JD
Colleen Cutcliffe Ph.D
Hugh Martin
John Eid Ph.D
Roelof Botha
Sequoia Capital

Other companies like Pendulum Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$298.33MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$327.39MM
Sector
 
 
Sector
Last Round Est. Valuation
$500MM

News

Whole Biome has pulled in $35 million in Series B financing from a list of investing titans, including Sequoia, Khosla, True Ventures, the Mayo Foundation and AME Ventues — just to name a few. The goal? To heal what ails you using microscopic bugs. Medical science has caught on in the last fe…
Whole Biome, a San Francisco, CA-based evidence-based microbiome company, secured $35m in Series B financing. The round brings total funding to $57m